The WEHI Protein Production Facility (PPF) is a specialized laboratory that produces high-quality recombinant proteins for research purposes. Recombinant proteins are artificially engineered by combining DNA from different organisms to create proteins with specific functions and properties.
The facility’s primary goal is to produce recombinant proteins that are difficult to obtain through natural sources or conventional methods. These proteins are used in drug development, vaccine production, and research applications.
The PPF employs state-of-the-art technology and advanced techniques to generate recombinant proteins in large quantities and with high purity levels. The process involves several stages, including DNA cloning, gene expression, protein purification, and quality control.
Highly skilled scientists and technicians carry out each stage with precision and accuracy. Overall, the PPF’s work plays a vital role in advancing scientific research and the development of new medical treatments. By producing high-quality recombinant proteins, the facility contributes to a deeper understanding of complex biological processes and the development of new therapies for a range of diseases.